top of page
Pharmaceutical Resources
Pharmaceutical Resources
Not only is it important to learn about all of the melanoma treatment options after a diagnosis, but you should also learn about all of the resources available, including those from pharmaceutical companies that manufacture your drug. Below are a few of the most commonly used treatments in melanoma and links to help you if your melanoma diagnosis becomes a financial burden on you and your family. We encourage you to take advantage of some or all of these resources.
-
Amgen’s Assist Program® (Imlygic®)
-
ArrayACTS™ (Braftovi™; Mektovi®)
-
Bristol-Myers Squibb’s Access Support® (Yervoy®; Opdivo®)
-
Genentech’s Access to Care Foundation® (Zelboraf®; Cotellic®)
-
Novartis’ Patient Assistance Now® (Tafinlar®; Mekinist®)
-
Merck’s Access Program® (Keytruda®)
bottom of page